# BioVectra Inc, Canada – FDA Inspections

Source: https://www.keypedia.com/companies/biovectra-inc/92848051-f6c1-47cb-b3ba-f9684e6881eb

> Inspection records and compliance data for BioVectra Inc. Access full analysis and detailed observations.

---

## Details

- Name: BioVectra Inc
- Country Name: Canada
- Address: Canada
- Country: Canada

## Related Documents

- Canada Inspection - BioVectra Inc - Inspection #85343 - 2024-12-09 — source: Canada, date: December 9, 2024
- Canada Inspection - BioVectra Inc - Inspection #76951 - 2021-07-26 — source: Canada, date: July 26, 2021
- Canada Inspection - BioVectra Inc - Inspection #68576 - 2017-10-31 — source: Canada, date: October 31, 2017
- Canada Inspection - BioVectra Inc - Inspection #7542 - 2015-07-06 — source: Canada, date: July 6, 2015

## Related Companies

- [Aerosol - Service AG](https://www.keypedia.com/companies/aerosol-service-ag/612dec4b-4b79-4749-a2f0-45a9c9e962b6)
- [Exemed Pharmaceuticals](https://www.keypedia.com/companies/exemed-pharmaceuticals/bcbbc713-ba0a-4143-aed3-848f6fbd1d43)
- [Tongling Jieya Biologic Technology Co. Ltd.](https://www.keypedia.com/companies/tongling-jieya-biologic-technology-co-ltd/c1a4f783-b299-4521-b6cb-d80526819cff)
- [Biohorma B.V.](https://www.keypedia.com/companies/biohorma-bv/5656eb68-0d1e-42f1-afaa-9658b4e33c14)
- [Lacsa (Pty) Ltd](https://www.keypedia.com/companies/lacsa-pty-ltd/3bbb4cb4-7698-4027-8dde-f9156193a680)
- [Weifa AS - Site 3 Kragero Plant](https://www.keypedia.com/companies/weifa-as-site-3-kragero-plant/bf3f133c-df35-43b3-9fe5-e0df6af30ed4)
- [Micronisierungs-Kontor-Oberrot](https://www.keypedia.com/companies/micronisierungs-kontor-oberrot/92878eb7-c040-427c-877d-39fb9eb2b738)
- [Canada Medical Ltd](https://www.keypedia.com/companies/canada-medical-ltd/a88a8664-c9f1-4b78-985f-c79b03866e96)
- [NovaSep Belgium](https://www.keypedia.com/companies/novasep-belgium/190868df-5aa5-450b-940f-386a1c2f4326)
- [Richter Pharma AG](https://www.keypedia.com/companies/richter-pharma-ag/eb97e5f5-4bdc-4b5d-b915-55b24e5a976b)